Piclidenoson in Trials for Psoriasis & RA; Plus Duzallo Approved in Europe
Delayed Care: Research Paints Complex Picture of Treatment Delays
EU Approves Marketing for Ixekizumab in Adults with PsA
Report on EU’s Experience with Biosimilar Drugs Released: Will U.S. Experience Be Similar?
European Group Offers Guidance on Managing Juvenile Dermatomyositis
Europe Launches New Fast Approval Scheme for Promising Drugs
New SLE Drug May Allow Patients to Reduce Steroid Use
Smarter Regulation Can Help Cut Drug Prices, Says EU Agency Head
